FDA Approves First Twice-Yearly HIV Prevention Medicine

Posted: 2025-06-19 20:54:32 UTC

@TIMETIME

#Medicine

#Prevention

#FDA

#HIV

#Lenacapavir

#PrEP

#Yeztugo

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-06-19 20:54:59 UTC

Verified By

Rollup News

The FDA has approved the first twice-yearly injectable medicine, lenacapavir (brand name Yeztugo), for HIV prevention.

FDA approval of lenacapavir as the first twice-yearly HIV prevention medicine

Convenience of a long-acting injectable PrEP option

Potential to improve PrEP adherence and reduce new HIV infections